These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1295313)

  • 1. Red blood cells as advanced drug delivery systems for antiviral nucleoside analogues.
    Magnani M; Rossi L; Casabianca A; Fraternale A; Schiavano G; Brandi G; Mannello F; Piedimonte G
    Adv Exp Med Biol; 1992; 326():239-45. PubMed ID: 1295313
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting antiviral nucleotide analogues to macrophages.
    Magnani M; Rossi L; Fraternale A; Casabianca A; Brandi G; Benatti U; De Flora A
    J Leukoc Biol; 1997 Jul; 62(1):133-7. PubMed ID: 9226004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: in vitro and in vivo studies.
    Magnani M; Rossi L; Brandi G; Schiavano GF; Montroni M; Piedimonte G
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6477-81. PubMed ID: 1631145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV-1 in monocyte/macrophage cultures by 2',3'-dideoxycytidine-5'-triphosphate, free and in liposomes.
    Szebeni J; Wahl SM; Betageri GV; Wahl LM; Gartner S; Popovic M; Parker RJ; Black CD; Weinstein JN
    AIDS Res Hum Retroviruses; 1990 May; 6(5):691-702. PubMed ID: 2163269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection.
    Magnani M; Casabianca A; Fraternale A; Brandi G; Gessani S; Williams R; Giovine M; Damonte G; De Flora A; Benatti U
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4403-8. PubMed ID: 8633079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feline immunodeficiency virus infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine-5'-triphosphate-loaded erythrocytes.
    Magnani M; Rossi L; Fraternale A; Silvotti L; Quintavalla F; Piedimonte G; Matteucci D; Baldinotti F; Bendinelli M
    AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1179-86. PubMed ID: 7826702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of murine retrovirus-induced immunodeficiency disease by dideoxycytidine and dideoxycytidine 5'-triphosphate.
    Rossi L; Brandi G; Fraternale A; Schiavano GF; Chiarantini L; Magnani M
    J Acquir Immune Defic Syndr (1988); 1993 Nov; 6(11):1179-86. PubMed ID: 8229653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes as carriers of the antiretroviral agent dideoxycytidine-5'-triphosphate.
    Oussoren C; Magnani M; Fraternale A; Casabianca A; Chiarantini L; Ingebrigsten R; Underberg WJ; Storm G
    Int J Pharm; 1999 Apr; 180(2):261-70. PubMed ID: 10370196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphono methoxypropyl)adenine.
    Franchetti P; Rossi L; Cappellacci L; Pasqualini M; Grifantini M; Balestra E; Forbici F; Perno CF; Serafini S; Magnani M
    Antivir Chem Chemother; 2001 May; 12(3):151-9. PubMed ID: 12959323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.
    Rensen PC; de Vrueh RL; van Berkel TJ
    Clin Pharmacokinet; 1996 Aug; 31(2):131-55. PubMed ID: 8853935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting HIV with liposome-encapsulated antivirals.
    Désormeaux A; Bergeron MG
    Zentralbl Bakteriol; 1995 Apr; 282(3):225-31. PubMed ID: 7549153
    [No Abstract]   [Full Text] [Related]  

  • 12. cycloSal-Pronucleotides of 2',3'-dideoxyadenosine and 2', 3'-dideoxy-2',3'-didehydroadenosine: synthesis and antiviral evaluation of a highly efficient nucleotide delivery system.
    Meier C; Knispel T; De Clercq E; Balzarini J
    J Med Chem; 1999 May; 42(9):1604-14. PubMed ID: 10229629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AZT and AZT-monophosphate prodrugs incorporating HIV-protease substrate fragment: synthesis and evaluation as specific drug delivery systems.
    Liotard JF; Mehiri M; Di Giorgio A; Boggetto N; Reboud-Ravaux M; Aubertin AM; Condom R; Patino N
    Antivir Chem Chemother; 2006; 17(4):193-213. PubMed ID: 17066898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HepDirect prodrugs for targeting nucleotide-based antiviral drugs to the liver.
    Erion MD; Bullough DA; Lin CC; Hong Z
    Curr Opin Investig Drugs; 2006 Feb; 7(2):109-17. PubMed ID: 16499280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for ribavirin prodrugs and delivery systems for reducing the side-effect hemolysis and enhancing their therapeutic effect.
    Guo H; Sun S; Yang Z; Tang X; Wang Y
    J Control Release; 2015 Jul; 209():27-36. PubMed ID: 25883028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug targeting systems for antiviral agents: options and limitations.
    Meijer DK; Jansen RW; Molema G
    Antiviral Res; 1992 Jun; 18(3-4):215-58. PubMed ID: 1416906
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inhibition of reproduction of the human immunodeficiency virus in cell culture by 2',3'-dideoxynucleoside-5'-phosphites].
    Karamov EV; Lukashov VV; Gorbacheva AP; Makarova TV; Kornilaeva GV; Tarusova NB; Kraevskiĭ AA
    Mol Biol (Mosk); 1992; 26(1):201-7. PubMed ID: 1508170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication.
    Romero DL; Busso M; Tan CK; Reusser F; Palmer JR; Poppe SM; Aristoff PA; Downey KM; So AG; Resnick L
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8806-10. PubMed ID: 1717988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovir.
    Franchetti P; Cappellacci L; Petrelli R; Vita P; Grifantini M; Rossi L; Pierigé F; Serafini S; Magnani M; Balestra E; Perno CF
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):953-7. PubMed ID: 18058516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-permeable dideoxyuridine 5'-monophosphate analogue inhibits human immunodeficiency virus infection.
    Sastry JK; Nehete PN; Khan S; Nowak BJ; Plunkett W; Arlinghaus RB; Farquhar D
    Mol Pharmacol; 1992 Mar; 41(3):441-5. PubMed ID: 1372082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.